Ibex Investors’s Intercure INCR Stock Holding History

Ibex Investors’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,886,274	Closed	-$2.77M	–	14
2025 Q2	$2.77M	Hold	1,886,274	–	–	2.84%	6
2025 Q1	$2.64M	Hold	1,886,274	–	–	3.51%	5
2024 Q4	$3.02M	Sell	1,886,274 -3,384	-0.2%	-$5.32K	2.6%	8
2024 Q3	$3.8M	Hold	1,889,658	–	–	4.35%	7
2024 Q2	$3.8M	Hold	1,889,658	–	–	3.92%	6
2024 Q1	$5.12M	Hold	1,889,658	–	–	6.6%	6
2023 Q4	$2.44M	Sell	1,889,658 -16,616	-0.9%	-$20.3K	2.95%	7
2023 Q3	$2.99M	Buy	1,906,274 +3,500	+0.2%	+$5.59K	3.4%	6
2023 Q2	$3.23M	Hold	1,902,774	–	–	4%	5
2023 Q1	$3.88M	Hold	1,902,774	–	–	5.75%	4
2022 Q4	$6.28M	Buy	1,902,774 +16,500	+0.9%	+$76.4K	4.2%	8
2022 Q3	$8.49M	Hold	1,886,274	–	–	4.36%	8
2022 Q2	$10.9M	Hold	1,886,274	–	–	6.86%	6
2022 Q1	$13.4M	Hold	1,886,274	–	–	0.59%	6
2021 Q4	$12.2M	Buy	1,886,274 +530,220	+39%	+$3.8M	4.1%	7
2021 Q3	$9.4M	Buy	+1,356,054	New	+$9.73M	1.99%	8

Other funds holding INCR

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Ibex Investors's INCR Position: Q3 2025 in Review

Ibex Investors sold out of Intercure (INCR) in Q3 2025, closing a stake of 1,886,274 shares — an estimated $2.77M sold.

Ibex Investors first reported a position in INCR in Q3 2021 and held it in 16 quarters. The position peaked at $13.4M in Q1 2022. 22 funds tracked by Wall St. Rank hold INCR as of Q3 2025.

Ibex Investors reported no remaining Intercure position as of Q3 2025 after selling out during the quarter.
Ibex Investors sold 1,886,274 Intercure shares in Q3 2025, an estimated $2.77M.
Ibex Investors first reported a position in Intercure in Q3 2021 and held it in 16 quarters.
Ibex Investors's Intercure position peaked at $13.4M in Q1 2022.
22 funds tracked by Wall St. Rank held Intercure as of Q3 2025.

Based on Ibex Investors's 13F filing for Q3 2025, filed 6 Nov 2025.